HCAT
HCAT
NASDAQ · Health Care

Health Catalyst Inc

$2.15
+0.06 (+2.87%)
As of Feb 8, 2:08 PM ET ·
Analyst Consensus
Hold
17
Analysts
High
Coverage
Buy 8 47%
Hold 9 53%
Sell 0 0%
Price Target
Analyst Price Target +1,044.7% upside
Low Target $16.02
Average Target $24.61
High Target $32.27
Current Price $2.15
Current
$2.15
Target
$24.61
$16.02 $24.61 avg $32.27
Scenario Analysis
Bear Case
$16.02
645.1%
Low target
Base Case
$24.61
+1,044.7%
Avg target
Bull Case
$32.27
+1,400.9%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$26.55
-91.9% from high
52-Week Low
$16.66
+-87.1% from low
Target vs 52W High
$24.61
-7.3% vs high
Next Earnings Report
Mar 3, 2026 · After Market Close
14d
until earnings
EPS Est: $0.09
Earnings in 14 days. Analyst targets may shift significantly after the report.
Peer Consensus — Health Care
Stock Consensus Analysts Buy % Target Upside
UNH
UnitedHealth Group Inc
Buy 34 68% $293.85 +6.2%
ABT
Abbott Laboratories
Buy 35 71% $123.47 +11.4%
ISRG
Intuitive Surgical Inc
Buy 42 69% $219.77 -55.0%
SYK
Stryker Corp
Strong Buy 36 75% $338.36 -5.6%
MDT
Medtronic Plc
Buy 35 57% $192.46 +87.0%
MCK
Mckesson Corp
Strong Buy 22 86% $307.39 -67.6%
HCA
Hca Healthcare Inc
Buy 31 58% $118.82 -76.3%
BSX
Boston Scientific Corp
Strong Buy 40 93% $136.36 +78.8%